GIMAP2

GIMAP2 is a TRAFAC-class GTPase that functions as a nucleotide-regulated scaffold on intracellular membranes, linking lipid droplet and endoplasmic reticulum biology to lymphocyte survival. In the GDP-bound state GIMAP2 is monomeric, but GTP binding stabilizes switch I to drive dimerization across the nucleotide-binding site and releases amphipathic helix α7 to enable higher-order oligomerization, forming scaffolds on the surface of lipid droplets (PMID:21059949). GIMAP2 possesses low intrinsic GTPase activity; heterodimerization with GIMAP7 trans-activates hydrolysis through a catalytic arginine supplied in trans, coupling the nucleotide cycle to partner-dependent regulation (PMID:23454188). Knockdown of GIMAP2 in cancer cells induces cell cycle arrest via downregulation of CDK4/CDK6 and altered apoptotic balance through changes in Bcl-2 family members (PMID:34992682).

1. 2010 High

   Determining how GIMAP2 senses nucleotide state established that GTP binding drives oligomerization through two distinct G-domain interfaces — a switch-I-mediated dimer interface and a switch-II-dependent helix-α7 interface — converting a monomeric GDP-bound protein into a higher-order scaffold.

   Evidence X-ray crystallography of nucleotide-free, GDP-bound, and GTP-bound GIMAP2 with site-directed mutagenesis in vitro

   PMID:21059949

   Open questions at the time

   • No effectors or cargo proteins that recognize the oligomeric scaffold have been identified
   • Physiological signals controlling GIMAP2 nucleotide loading are unknown
   • Oligomer stoichiometry in vivo has not been defined
2. 2010 High

   The oligomeric scaffold was shown to localize to lipid droplet surfaces in T cells, establishing GIMAP2 as a GTP-dependent membrane-associated platform rather than a cytosolic signaling GTPase.

   Evidence Fluorescence imaging of GIMAP2 constructs in Jurkat T cells

   PMID:21059949

   Open questions at the time

   • Mechanism of membrane anchoring (lipid interaction vs. protein receptor) is unresolved
   • Functional consequence of lipid droplet association for T cell biology was not tested
3. 2013 High

   The puzzle of GIMAP2's very low intrinsic GTPase activity was resolved by demonstrating that GIMAP7 heterodimerization trans-activates hydrolysis, with GIMAP7 supplying a catalytic arginine to the GIMAP2 active site, thereby linking nucleotide cycling to inter-GIMAP partnering.

   Evidence Crystal structure of GTP-bound GIMAP7 homodimer, GTPase assays, and mutagenesis of catalytic arginine

   PMID:23454188

   Open questions at the time

   • Whether other GIMAP family members also trans-activate GIMAP2 is unknown
   • Downstream consequences of GTP hydrolysis for scaffold disassembly have not been visualized in cells
4. 2013 Medium

   GIMAP7 was identified as a lipid droplet-resident binding partner of GIMAP2, and their expression was found to be differentially regulated in T cell lymphoma lines, suggesting coordinated regulation of the heterodimer on lipid droplets.

   Evidence Co-localization studies and expression profiling across human T cell lymphoma lines

   PMID:23454188

   Open questions at the time

   • No reciprocal co-immunoprecipitation or endogenous interaction validation was performed
   • Functional significance of differential expression in lymphoma remains unexplored
5. 2020 Medium

   GIMAP2 localization was extended beyond lipid droplets to include the endoplasmic reticulum, indicating dual compartment residence that may reflect a lipid droplet biogenesis or ER-lipid droplet contact site role.

   Evidence Super-resolution N-SIM microscopy with organelle-specific dyes and immunofluorescence of endogenous GIMAP2 in MDA-MB-436 cells

   PMID:32306002

   Open questions at the time

   • Whether ER and lipid droplet pools represent distinct functional states is unknown
   • No perturbation experiment linked ER localization to a specific function
6. 2021 Medium

   Loss-of-function experiments established that GIMAP2 promotes cell cycle progression and modulates apoptotic balance, connecting the GTPase scaffold to CDK4/CDK6–Rb signaling and Bcl-2 family regulation.

   Evidence siRNA knockdown in oral squamous cell carcinoma cells with immunoblotting for cell cycle and apoptosis regulators

   PMID:34992682

   Open questions at the time

   • No upstream pathway placement — whether effects are direct or indirect is unresolved
   • Findings are from a single cancer cell type and have not been extended to lymphocytes
   • Relationship between GTPase activity/lipid droplet scaffolding and cell cycle control is unknown

• How GIMAP2's GTP-dependent oligomeric scaffold on lipid droplets and the ER mechanistically connects to downstream control of cell survival and proliferation remains the central open question.
• No direct substrates, effectors, or cargo have been identified for the GIMAP2 scaffold
• The physiological GEF or nucleotide exchange mechanism is unknown
• In vivo genetic models (knockout mice or human genetic studies) have not been reported for GIMAP2 specifically